The risk of fractures associated with thiazolidinediones: a self-controlled case-series study.
The results of clinical trials have suggested that the thiazolidinedione antidiabetic agents rosiglitazone and pioglitazone are associated with an increased risk of fractures, but such studies had limited power. The increased risk in these trials appeared to be limited to women and mainly involved f...
Main Authors: | Ian J Douglas, Stephen J Evans, Stuart Pocock, Liam Smeeth |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-09-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC2741577?pdf=render |
Similar Items
-
Glycemic Control with Thiazolidinedione Is Associated with Fracture of T2DM Patients.
by: Hsin-Hung Chen, et al.
Published: (2015-01-01) -
USE OF THIAZOLIDINEDIONES AND RISK OF OSTEOPOROTIC FRACTURE: DISEASE OR DRUGS?
by: Bazelier, M, et al.
Published: (2010) -
USE OF THIAZOLIDINEDIONES AND RISK OF OSTEOPOROTIC FRACTURE: DISEASE OR DRUGS?
by: Bazelier, M, et al.
Published: (2012) -
Use of thiazolidinediones and risk of osteoporotic fracture Disease or drugs?
by: de Vries, F, et al.
Published: (2010) -
Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?
by: Bazelier, M, et al.
Published: (2012)